Cov kws formulation "Anavenol". Cov lus qhia rau kev siv

Cov kws formulation "Anavenol" qhia ntawv nyob rau daim ntawv thov hais, nyob rau hauv daim ntawv ntawm pellets ua los ntawm ntsuab, lawv zoo - lenticular. Thaum lub lem ntawm cov tshuaj yog tau mus pom cov tub ntxhais ntawm ib tug daj xim, tas ntawm cov npoo ntawm cov ntsuab thiab dawb lub tsho.

Nyob rau hauv ib dragées muaj 0,58 milligram dihydroergocristine mesylate, 1,62 milligram trihydrate esculin, 32,66 milligrams rutoside trihydrate. Qhov saum toj no active tshuaj yog active Cheebtsam.

Ntxiv Cheebtsam sawv cev pob kws starch, lactose, stearic acid, stearin, povidone, sodium ntsev ntawm carboxymethyl starch, sucrose, talc, polyvinyl acetate, carmellose sodium ntsev, thiab karnuabskim dawb ciab, titanium dioxide, patented xiav xim thiab quinoline daj.

Lub medicament "Anavenol" (phau ntawv qhia comprises cov ntaub ntawv) yog hais txog kev soj ntsuam thiab pharmacological pab pawg neeg venotonic, angioproteguoe txhais tau tias.

Tshuaj yog ib tug ua ke. Nws ua venotonic nyhuv, li no kom txhob muaj cov permeability ntawm lub vascular phab ntsa thiab kev txhim kho microcirculation.

Dihydroergocristine, ib feem ntawm cov tshuaj, - semisynthetic derivative pawg ntawm ergot alkaloids. Qhov no cov ntaub ntawv uas muaj ib qho kev alpha-adrenoceptor thaiv cov hlab cov nyhuv muab dilation ntawm arterioles, me me nce venous laus, pab txoj kev peripheral cov ntshav ncig. Qhov kuaj pom rutoside thiab esculin muab antiekssudativnoe thiab vasoprotective kho nyhuv.

Tom qab qhov ncauj thawj coj "Anavenol" npaj phau ntawv qhia sau ntawv hais txog ib tug peb lub hlis twg dihydroergocristine absorbed nyob rau hauv txoj hnyuv ib ntsuj av. 68% ntawm cov yam khoom uas yog ua txhua yam rau cov ntshav proteins. Nws yoojyim lub cev nyob rau hauv lub bile. Lub ib nrab-lub neej lub sij hawm - txog kaum plaub teev. Hais tias active tshuaj yog tau txeem lub tsho me nyuam thiab tso tawm nrog mis nyuj.

Medicament "Anavenol" phau ntawv qhia prescribes siv los mus tshem tawm mob venous insufficiency (xws li post-thrombotic syndrome), predvarikoznogo syndrome. Nyob rau hauv kev npaj no cov complex txoj kev kho yog qhia rau tej kab mob raws li trophic crus rwj, thrombosis, raws li zoo raws li nyob rau hauv post-traumatic lub microcirculation mob (e.g., tom qab ib tug ntev lub sij hawm ntawm immobility lub sab nqua). Nyob rau hauv kev txiav txim kom tsis txhob muaj teeb meem yuav tsum tau hais tias cov tshuaj thiaj tau tuaj rau cov kws muaj txuj tswv yim pom zoo.

Kws neeg sawv cev "Anavenol" qhia ceev faj yuav tsum tsis txhob yuav siv nyob rau hauv cov ntaub ntawv ntawm intolerance ntawm nws lub Cheebtsam, raws li zoo raws li nyob rau hauv tej yam kev mob yus muaj los ntawm ntau zog los ntshav. Tsis tas li ntawd nws yog ua rau cov neeg nyob rau hauv lub hnub nyoog ntawm kaum tsib xyoos; cov poj niam uas ua tim ib tug me nyuam (nyob rau hauv thaum ntxov ua sawv); kev pub niam mis niam.

Nyob rau hauv thawj zaug rau theem ntawm kev kho mob (thaum lub sij hawm thawj lub lim tiam) yuav tsum noj ob ntsiav tshuaj peb zaug ib hnub twg. Tom qab ntawd, cov tshuaj yog pom zoo kom txo kom txog thaum ib dragees nrog tib zaus. Cov tshuaj no yog coj tom qab ib tug noj mov, nqos nws tag nrho, ntxuav cia nrog ib tug txaus tus nqi ntawm cov kua.

Lub medicament "Anavenol" (paub meej tias ratings) yog, raws li ib tug txoj cai, zoo heev. Tsis tshua muaj neeg uas tsis tshua muaj kev tsis haum tshuaj loj (daim tawv nqaij ua pob ua xyua, khaus), menorrhagia, mob taub hau, qaug zog, mob quav, ntuav, xeev siab, o ntawm lub mucosa kuj kaw qhov ntswg nqe vaj lug kub.

Overdosing medicament ces piav saum toj no yog los ntawm muaj zog phiv. Nyob rau hauv cov ntaub ntawv no, pom zoo pais plab lavage.

Hais tias kev npaj yuav yuav tsis muaj ib tug tshuaj.